Biofidelity
A veteran executive with over 35 years’ experience in high growth life science and healthcare businesses, Dr Dreismann was a pioneer in the early adoption of PCR technologies. Formerly President & CEO of Roche Molecular Systems, he now serves on the boards of multiple healthcare companies in the US, Europe and Israel.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Biofidelity
1 followers
Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences.